Adaptimmune Therapeutics Plc American...

ADAP

4.92

+0.03

+0.6%

After Hours:

4.92

0.00

0.0%

Please Subscribe or Register

Login|Subscribe|Register

Stock Price
Open: 4.89
Prev. Close: 4.89
Low/Hi: 4.69 - 4.96
52-Week: 3.76 - 9.33
Volumes
Equity: 159,366
90-Day Avg: 259,945
Option: 7
90-Day Avg: 47
Volatility
Today: 67.4
20-Day: 60.3
52-Week: 69.9
30-Day IV: 64.1 +3.7
IV Rank: 0.64 (Moderate)
Fundamental
Div. Yield: 0.0%
Earnings: 2-Aug (Est.)
P/E Ratio:
Market Cap: 457.3 M
Stock Type: Common - ADR | Sector: Healthcare | Industry: Biotechnology

ADAP Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Mar-2017 31-Dec-2016 30-Sep-2016 30-Jun-2016
Cash and Cash Equivalents 170,559 158,779 140,440 150,894
Short Term Investments 0 0 0 0
Investments - - - -
Accounts Receivable 107 1,480 0 0
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 0 15,798 0 0
Net Property Plant and Equipment 35,092 27,899 15,086 13,444
Other Current Assets 52,266 22,694 59,104 67,288
Current Assets 222,932 198,751 199,544 218,182
Goodwill and Intangibles 1,310 1,268 1,127 1,010
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 265,980 234,515 222,644 239,560
Short Term Debt 0 0 0 0
Other Non-Current Assets 6,646 6,597 6,887 6,924
Accounts Payable 5,177 11,350 3,193 2,474
Accrued Liabilities and Other Payables 15,110 17,528 9,954 7,723
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 57,654 68,373 42,640 42,569
Other Current Liabilities 11,625 11,392 9,514 9,940
Accumulated Other Comprehensive Income -14,366 -14,249 -13,788 -13,011
Preferred Stock 0 0 0 0
Current Liabilities 31,912 40,270 22,661 20,137
Common Stock 801 683 682 682
Other Non-Current Liabilities 25,742 28,103 19,979 22,432
Additional Paid-In Capital 405,165 341,200 339,188 336,904
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -183,274 -161,492 -146,078 -127,584
Total Equity 208,326 166,142 180,004 196,991
Period Ending 31-Dec-2016
Cash and Cash Equivalents 158,779
Short Term Investments 0
Investments -
Accounts Receivable 1,480
Inventory 0
Loans -
Prepaid Expenses 15,798
Net Property Plant and Equipment 27,899
Other Current Assets 22,694
Current Assets 198,751
Goodwill and Intangibles 1,268
Long Term Investments 0
Other Assets -
Long Term Receivables 0
Total Assets 234,515
Short Term Debt 0
Other Non-Current Assets 6,597
Accounts Payable 11,350
Accrued Liabilities and Other Payables 17,528
Long Term Debt 0
Other Liabilities -
Current Portion of Long Term Debt 0
Total Liabilities 68,373
Other Current Liabilities 11,392
Accumulated Other Comprehensive Income -14,249
Preferred Stock 0
Current Liabilities 40,270
Common Stock 683
Other Non-Current Liabilities 28,103
Additional Paid-In Capital 341,200
Treasury Stock 0
Other Equity 0
Retained Earnings -161,492
Total Equity 166,142